- Yale Medicine Dermatology is pioneering new treatments for vitiligo and related autoimmune diseases such as alopecia areata and atopic dermatitis (eczema).
- Leading experts in dermatology, we are conducting research on the most difficult-to-treat skin disorders.
- We use the latest technology and research to treat patients with skin disorders—from the most common to the most rare.
If you’ve heard of fashion model Winnie Harlow, you may already be familiar with a skin condition that affects about 3 million people in the United States and about 70 million worldwide: vitiligo.
It happens when skin loses its pigment (coloring), causing white patches of skin that can sometimes cover the entire body. While Harlow has found stardom, that is not the reality for the vast majority of people with vitiligo.
“Many, if not most, people with vitiligo feel self-conscious,” says Brett King, MD, PhD, a Yale Medicine dermatologist and an associate professor of dermatology at Yale School of Medicine. “Feelings range from embarrassment to clinical depression.”
“When vitiligo is very noticeable, patients often report that people will avoid touching them, even in day-to-day transactions such as when shaking hands or exchanging money at a restaurant,” says Dr. King.
Although there is no cure for vitiligo, there may be hope. At Yale Medicine Dermatology, Dr. King is performing research on the use of a new class of medicines for the treatment of the disorder.